Beta-Glucans: study protocols
13 study groups say how much Beta-Glucans participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
88 products in our catalogue print how much Beta-Glucans a serving holds.
Most common: 250 mg to 500 mg, 36% of 88 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 4 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 6 |
| 50 mg to 100 mg | 13 |
| 100 mg to 250 mg | 29 |
| 250 mg to 500 mg | 32 |
| over 500 mg | 2 |
Dose per serving from research
13 study groups in 4 studies say how much Beta-Glucans participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 g to 5 g, 100% of 13 study groups.
| Daily dose | Study groups |
|---|---|
| 2.5 g to 5 g | 13 |
Commonly used together
None of these 13 study groups took Beta-Glucans with anything else.
13 study groups
| Study | |||
|---|---|---|---|
| Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial 2010 · 3 g high-MW oat β-glucan · People with LDL cholesterol ≥3.0 and ≤5.0 mmol/L; age and sex range not specified | 3 g | 4 weeks | 86 |
| Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians 2011 · 3 H (3 g high-MW oat β-glucan) · Healthy men and women aged 35–70 with LDL-C of 3.0–5.0 mmol/L | 3 g | 4 weeks | 86 |
| A randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study 2020 · beta-glucan supplement · Italian adults aged 20–65 with moderate hypercholesterolemia and low estimated 10-year cardiovascular risk | 3 g | 8 weeks | 83 |
| Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial 2010 · 4 g medium-MW oat β-glucan · People with LDL cholesterol ≥3.0 and ≤5.0 mmol/L; age and sex range not specified | 4 g | 4 weeks | 67 |
| Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians 2011 · 4 M (4 g medium-MW oat β-glucan) · Healthy men and women aged 35–70 with LDL-C of 3.0–5.0 mmol/L | 4 g | 4 weeks | 67 |
| Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial 2010 · 3 g medium-MW oat β-glucan · People with LDL cholesterol ≥3.0 and ≤5.0 mmol/L; age and sex range not specified | 3 g | 4 weeks | 64 |
| Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial 2010 · 4 g low-MW oat β-glucan · People with LDL cholesterol ≥3.0 and ≤5.0 mmol/L; age and sex range not specified | 4 g | 4 weeks | 63 |
| Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians 2011 · 3 M (3 g medium-MW oat β-glucan) · Healthy men and women aged 35–70 with LDL-C of 3.0–5.0 mmol/L | 3 g | 4 weeks | 63 |
| Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians 2011 · 4 L (4 g low-MW oat β-glucan) · Healthy men and women aged 35–70 with LDL-C of 3.0–5.0 mmol/L | 4 g | 4 weeks | 63 |
| The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women 2007 · 3 g high molecular weight BBG · Men and women with hypercholesterolaemia/moderate dyslipidaemia; ages not reported | 3 g | 10 weeks | — |